Samsung Electronics takes top stake in US biotech firm Element Biosciences

Samsung Electronics Co. said Wednesday it has invested $175 million in an expanded Series E funding round for US-based genomics technology company Element Biosciences, becoming the company's largest shareholder.

The investment follows Samsung Electronics' participation in Element's Series D funding round in July 2024, the South Korean technology giant said in a press release.

Headquartered in San Diego, Element Biosciences develops next-generation DNA sequencing and multiomics platforms used in ...